Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis

Abdiwahab A Musse1, George Harauz

  • 1Department of Molecular and Cellular Biology, Biophysics Interdepartmental Group, University of Guelph, Ontario N1G 2W1, Canada.

Insights

Myelin basic protein (MBP) modifications, like deimination, impact myelin sheath structure and function. Deimination correlates with multiple sclerosis (MS) severity, potentially driving autoimmune pathogenesis.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Immunology

Background:

  • Myelin basic protein (MBP) is crucial for myelin sheath adhesion in the central nervous system.
  • Posttranslational modifications of MBP are dynamic during development and degeneration.
  • Deimination (citrullination) of MBP is linked to multiple sclerosis (MS) severity.

Purpose of the Study:

  • To describe the structural and functional consequences of MBP deimination.
  • To investigate the role of MBP deimination in healthy and diseased myelin.
  • To explore the potential role of deimination in the autoimmune pathogenesis of MS.

Main Methods:

  • The study focuses on analyzing the structural and functional changes associated with MBP deimination.
  • Investigates the impact of deimination on MBP's interaction with myelin membranes and other proteins.
  • Examines how deimination affects the accessibility of immunodominant epitopes.

Main Results:

  • MBP deimination alters its interactions with myelin membranes and associated proteins.
  • The degree of MBP deimination correlates with the severity of multiple sclerosis.
  • Deimination affects the topological accessibility of a key MBP epitope.

Conclusions:

  • MBP deimination has significant structural and functional consequences in myelin.
  • Deimination may represent a primary defect preceding neurodegeneration in MS.
  • MBP deimination plays a critical role in the autoimmune pathogenesis of multiple sclerosis.

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Nervous Tissue: Myelin01:25

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...